FM

Frazier Management Portfolio holdings

AUM $1.12M
This Quarter Return
+21.81%
1 Year Return
+150.24%
3 Year Return
+430.4%
5 Year Return
+1,926.83%
10 Year Return
–
AUM
$415M
AUM Growth
+$415M
Cap. Flow
+$5.28M
Cap. Flow %
1.27%
Top 10 Hldgs %
87.52%
Holding
17
New
–
Increased
3
Reduced
–
Closed
–

Top Buys

1
ALPN
Alpine Immune Sciences, Inc. Common Stock
ALPN
$2.55M
2
KZR icon
Kezar Life Sciences
KZR
$2.13M
3
NBRV
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
$596K

Top Sells

No sells this quarter

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
ANAB icon
1
AnaptysBio
ANAB
$569M
$169M 40.73% 2,316,447 – –
KRYS icon
2
Krystal Biotech
KRYS
$4.27B
$28.8M 6.93% 875,000 – –
COLL icon
3
Collegium Pharmaceutical
COLL
$1.22B
$28.6M 6.88% 1,887,332 – –
GRTS
4
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
$27.4M 6.6% 2,061,758 – –
ALNA
5
DELISTED
Allena Pharmaceuticals, Inc. Common Stock
ALNA
$23.4M 5.63% 3,330,373 – –
TPST icon
6
Tempest Therapeutics
TPST
$44M
$20.9M 5.04% 1,396,615 – –
IOVA icon
7
Iovance Biotherapeutics
IOVA
$807M
$20.8M 5.01% 2,188,331 – –
ALPN
8
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
$17.6M 4.25% 2,571,450 +372,439 +17% +$2.55M
SRRA
9
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$13.9M 3.34% 8,112,121 – –
APTX
10
DELISTED
Aptinyx Inc. Common Stock
APTX
$12.9M 3.11% 3,190,079 – –
ITRM icon
11
Iterum Therapeutics
ITRM
$30.2M
$12.2M 2.93% 1,538,316 – –
NBRV
12
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
$10.4M 2.5% 4,256,526 +244,152 +6% +$596K
ETTX
13
DELISTED
Entasis Therapeutics Holdings Inc.
ETTX
$9.12M 2.2% 1,349,953 – –
SYBX icon
14
Synlogic
SYBX
$17M
$6.57M 1.58% 865,407 – –
KZR icon
15
Kezar Life Sciences
KZR
$28.9M
$6.57M 1.58% 370,081 +120,081 +48% +$2.13M
BLCM
16
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
$3.54M 0.85% 1,051,441 – –
CDTX icon
17
Cidara Therapeutics
CDTX
$1.66B
$3.48M 0.84% 1,312,258 – –